Legal Representation
Attorney
Jason A. Duva
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 22, 2005 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 13, 2004 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| Feb 26, 2004 | I | PAPER RECEIVED | Loading... | |
| Sep 10, 2003 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Feb 21, 2003 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Nov 18, 2002 | I | PAPER RECEIVED | Loading... | |
| Nov 18, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 18, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 24, 2002 | PCGR | O | PETITION TO DIRECTOR - GRANTED | Loading... |
| May 21, 2002 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Mar 25, 2002 | PCRC | I | PETITION TO DIRECTOR RECEIVED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely amphetamines, for treatment of attention deficit disorder and hyperactivity
First Use Anywhere:
19980100
First Use in Commerce:
19980100
Additional Information
Design Mark
The mark consists of the color orange, the letters "AD," and the design of a tablet. The entire mark appears in the color orange, and color is claimed as an element of the mark.
Other
The lining in the drawing shown on the top and sides of the tablet is for shading purposes only, and is not claimed as an element of the mark.
Classification
International Classes
005